
Pharmacists enhance community health by providing vital services such as vaccinations and chronic disease management, despite facing reimbursement and recognition challenges.

Pharmacists enhance community health by providing vital services such as vaccinations and chronic disease management, despite facing reimbursement and recognition challenges.

Despite a significant leap in the development of asthma therapies, depression symptoms continue to be a roadblock for improved outcomes.

Pharmacists play a crucial role in managing polypharmacy, enhancing patient care through medication reconciliation and personalized therapy strategies.

A plant-based lifestyle intervention can lead to diabetes remission and weight loss, transforming traditional diabetes management strategies.

Pharmacists transform health care by offering essential services, tackling the opioid crisis, and adapting to new initiatives for better patient outcomes.

With a multitude of concerns surrounding corticosteroids for asthma, researchers explore the overall clinical and economic burden of these drugs.

High-dose vitamin D3 shows promise in improving metabolic health for type 2 diabetes patients, enhancing glycemic control alongside traditional treatments.

By uncovering insights on the regulatory framework regarding Rx-to-OTC rejections, researchers aim to address key challenges and concerns impeding self-care management.

A recent survey reveals that over half of US patients face challenges with prescription costs, highlighting the need for better cost transparency and support.

Pharmacists enhance travel medicine by offering tailored consultations, risk assessments, and vaccine management, ensuring safe international travel for patients.

As pharmacists continue to take on greater clinical roles, the growing need to address mental health concerns is reaching a boiling point.

The American Academy of Pediatrics responds to recent HHS vaccine guideline changes with its own schedule for childhood and adolescent patients.

In part 2, Alyssa Billingsley, PharmD, explores some of the recent switches that made waves in the US and how they impact pharmacy operations as well as patient outcomes.

Consultant pharmacists enhance vaccination efforts in long-term care, addressing challenges like vaccine fatigue while advocating for age-friendly care and improved patient outcomes.

With 15 more drugs’ negotiations announced and 1 drug being renegotiated, new prices are set to take effect at the start of 2028.

As respiratory virus season approaches, misinformation threatens lives; understanding vaccines is crucial for protecting our communities and future.

As various regions across the country experience snowstorms, pharmacies must be proactive about ensuring minimal disruptions to their operations.

The Pharmacy Quality Alliance enhances patient outcomes by addressing social determinants of health through effective community partnerships and pharmacist involvement.

During the week of Roe v Wade’s 53rd anniversary, debates between pro-choice and pro-life groups are yet again reaching the national stage.

GLP-1 therapies gain popularity, but patient adherence struggles due to fragmented support and emotional barriers.

Natalie DiPietro Mager, PharmD, PhD, explores some of the policies that have bolstered maternal health care and what can still be done to further improve patient outcomes.

Amid evolving recommendations for products like acetaminophen as well as influenza vaccines, researchers revisit the role of pharmacists in addressing adolescents’ cold and flu symptoms.

The new provisions would be the first major update to a Medicare Part D statute impacting the pharmacy industry in nearly 20 years.

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

In part 2, ASCP’s senior policy expert James Lewis breaks down the MTF system and how it is impacting the thousands of pharmacies that dispense Medicare-covered drugs.

Medical organizations challenge the government's revised childhood vaccine schedule, urging Congress for immediate oversight and action to protect public health.

Lumateperone shows promising remission rates for major depressive disorder, offering hope for sustained relief in adults when combined with antidepressants.

Pharmacists address the hidden risks of legal substances like nitrous oxide and kratom, emphasizing the need for public education and safety measures.

Fremanezumab significantly reduces migraine days in children and adolescents, offering a vital preventive option for managing episodic migraines.

Gestational diabetes significantly impacts postpartum cardiovascular health, especially in women over 35, highlighting the need for timely interventions.